证券代码：605123 证券简称：派克新材 公告编号：2025-054 无锡派克新材料科技股份有限公司 关于使用暂时闲置募集资金进行现金管理的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 履行的审议程序：2025年10月29日，无锡派克新材料科技股份有限公司（以下简称"公司"）召开第四 届董事会第六次会议，审议通过了《关于使用暂时闲置的募集资金进行现金管理的议案》，同意公司使 用最高额度不超过4亿元人民币的暂时闲置的募集资金进行现金管理，该4亿元额度可滚动使用，具体内 容详见上海证券交易所网站（www.sse.com.cn）上发布的相关公告（公告编号：2025-050）。 ● 特别风险提示：尽管公司本次购买的理财产品为安全性高、流动性好、低风险的结构性存款，但金融 市场受宏观经济、财政及货币政策的影响较大，不排除该项投资可能受到市场波动的影响。 一、本次现金管理概述 （一）本次现金管理的目的 在保证公司募投项目所需资金和保证募集资金安全的前提下，合理利用闲置的募集资金，提高暂时闲置 的募集资金的使用 ...

派克新材公告称，公司召开第四届董事会第六次会议，同意使用最高额度不超4亿元暂时闲置募集资金 进行现金管理，该额度可滚动使用。公司本次进行现金管理的投资总额为1.3亿元，投资种类为银行结 构性存款，分别向中国银行和宁波银行购买，产品期限86 - 107天不等，年化收益率在0.59% - 2.9%之 间。截至2025年9月30日，公司货币资金为21.86亿元，本次认购占比5.95%，不会影响募投项目和主营 业务发展。 ...

Core Viewpoint - The company has established a dedicated settlement account for cash management of idle raised funds, aiming to enhance the efficiency of fund utilization while ensuring the normal progress of investment projects [3][4][12]. Group 1: Establishment of Settlement Account - The company has opened a dedicated settlement account for cash management at Industrial Bank Co., Ltd. [3] - This account will exclusively be used for the settlement of temporarily idle raised funds for purchasing financial products, ensuring no non-raised funds are stored [3]. Group 2: Cash Management Overview - The purpose of cash management is to improve the efficiency of raised fund utilization without affecting the construction progress of investment projects [4]. - The funds used for cash management are temporarily idle raised funds [5]. Group 3: Fundraising and Usage - The company has been approved to issue convertible bonds, raising a total of 907.939 million shares with a total fundraising amount of 907.939 million RMB, after deducting issuance costs [6][8]. - All raised funds are stored in a dedicated account managed under a tripartite supervision agreement [8]. Group 4: Approval Process - The board of directors and the supervisory board have approved the use of up to 40 million RMB of idle raised funds for cash management, with a validity period of 12 months [9]. Group 5: Cash Management Specifics - The company will select low-risk, capital-preserving financial products for cash management, with a focus on liquidity and safety [10][11]. - The finance department will monitor the net value changes of the products and take necessary measures to control investment risks [11]. Group 6: Impact on the Company - The cash management of idle raised funds will not affect the normal construction of investment projects or the normal use of raised funds, and it aims to increase returns for the company and its shareholders [12].

Core Viewpoint - The company plans to utilize idle raised funds for cash management to enhance fund efficiency and generate returns for shareholders while ensuring the safety of the funds [3][12]. Investment Overview - **Investment Purpose**: The aim is to improve the efficiency of raised funds and ensure that the normal implementation of fundraising projects is not affected while increasing returns for the company and its shareholders [3]. - **Investment Amount**: The total amount for cash management is set at 50 million RMB [4]. - **Source of Funds**: The funds for this cash management initiative will come from idle raised funds [4]. Fundraising Background - The company was approved by the China Securities Regulatory Commission to issue up to 51.31 million shares at a price of 16.84 RMB per share, raising a total of approximately 864.06 million RMB, with a net amount of about 784.17 million RMB after deducting issuance costs [5]. Approval Process - The board of directors and the supervisory board approved the cash management proposal on April 17, 2025, allowing the use of up to 220 million RMB of idle raised funds within a 12-month period [7]. Risk Analysis and Control Measures - **Risk Analysis**: While the company intends to invest in high-safety, liquid principal-protected financial products, there are risks associated with market fluctuations and macroeconomic changes that could affect returns [8]. - **Control Measures**: The company will adhere to regulations, monitor the investment closely, and take necessary actions to mitigate risks if adverse factors are identified [9][10]. Impact on the Company - The cash management of idle raised funds is expected to enhance fund efficiency without affecting the normal operations of fundraising projects, thereby potentially increasing overall performance and returns for shareholders [12]. - As of June 30, 2025, the company's cash balance was approximately 1,004.31 million RMB, with the cash management amount representing about 4.98% of this balance, indicating minimal impact on the company's financial health [13].

Core Viewpoint - Shanghai Liangxin Electric Co., Ltd. has approved the use of up to RMB 200 million of temporarily idle raised funds for cash management, ensuring that it does not affect the normal operation of fundraising projects [1] Group 1: Cash Management Plan - The company will use the idle funds to invest in safe and liquid principal-protected investment products [1] - The cash management will be executed through structured deposit agreements with China Merchants Bank and Industrial Bank [1] Group 2: Impact on Daily Operations - The investment in structured deposits is designed to enhance fund utilization efficiency and generate investment returns without altering the intended use of the raised funds [6] - As of the announcement date, the total amount of idle funds used for cash management that has not yet matured is RMB 200 million, which is within the approved limit [6]

Core Viewpoint - The company, Shanghai Miaokelan Duo Food Technology Co., Ltd., has approved the use of temporarily idle raised funds for cash management to enhance fund utilization efficiency and increase returns for the company and its shareholders [2][10]. Investment Overview - **Investment Purpose**: The aim is to improve the efficiency of raised funds and ensure that normal operations and project investments are not affected while increasing company returns [4]. - **Investment Amount**: The total amount for cash management is set at 310 million yuan [5]. - **Source of Funds**: The funds are sourced from temporarily idle raised funds, which were raised through a non-public offering of shares totaling approximately 2.98 billion yuan after deducting issuance costs [6]. Investment Details - **Investment Method**: The company has purchased two structured deposit products from Shanghai Pudong Development Bank, which are characterized as high safety and liquidity, meeting the capital preservation requirements [8]. - **Investment Duration**: The duration of the cash management products is 49 days [9]. Approval Process - The board and supervisory committee meetings held on November 18, 2024, approved the cash management proposal, allowing the use of up to 1.75 billion yuan of temporarily idle raised funds for a period of 12 months [10]. Impact on the Company - The cash management will not affect the company's normal operations or the implementation of investment projects, and it is expected to enhance returns for shareholders [14]. - As of June 30, 2025, the company's cash balance was approximately 655.62 million yuan, with the cash management investment amounting to 310 million yuan, representing 47.28% of the cash balance [14]. - The accounting treatment for the cash management will classify the principal as trading financial assets, with returns recorded as investment income [14]. Opinions from Supervisory and Sponsoring Institutions - The supervisory committee supports the cash management initiative, stating it will enhance fund efficiency and is in the best interest of shareholders [15]. - The sponsoring institution, Dongfang Securities, confirms that the cash management decision has followed necessary approval procedures and complies with relevant regulations [16].

Core Viewpoint - Ningbo Helit Technology Co., Ltd. has announced the use of temporarily idle raised funds for cash management, which has been approved by the company's board and supervisory board [2][10]. Group 1: Basic Information - The company plans to use RMB 73.5 million for cash management, sourced from temporarily idle funds raised through a specific stock issuance [5][8]. - The total amount raised from the issuance of 47,040,000 shares at a price of RMB 12.69 per share was RMB 596.94 million, with a net amount of RMB 586.09 million after deducting related costs [5][7]. Group 2: Investment Purpose and Method - The purpose of the investment is to improve the efficiency of fund utilization without affecting the normal operation of the fundraising projects, thereby increasing returns for the company and its shareholders [4][11]. - The cash management products purchased are structured deposits with a principal-protected floating return, ensuring high safety and liquidity [8][16]. Group 3: Approval and Oversight - The board and supervisory board approved the cash management plan during their respective meetings held on March 31, 2025, allowing for a maximum of RMB 400 million to be used within 12 months [10][11]. - The supervisory board supports the cash management initiative, stating it does not conflict with the implementation of fundraising projects and is beneficial for improving fund utilization efficiency [11][16]. Group 4: Impact on the Company - The use of idle funds for cash management is intended to ensure the necessary funding for investment projects while enhancing the utilization rate of raised funds, leading to higher interest income and increased shareholder returns [14][15]. - The company will adhere to relevant accounting standards for the cash management activities, with specific treatments to be confirmed in annual audits [15].

Core Viewpoint - Hefei Huitong Holdings Co., Ltd. has successfully redeemed part of its cash management products and continues to manage its idle raised funds to enhance returns for the company and its shareholders [2][11]. Cash Management Redemption - The company has redeemed a total of 250 million yuan from cash management products, receiving an interest income of 2.9967 million yuan [2][5]. Ongoing Cash Management - The company is continuing its cash management with an investment of 230 million yuan in bank structured deposits [3][5]. - The board of directors approved the use of up to 300 million yuan of temporarily idle raised funds for cash management, ensuring that it does not affect the construction of investment projects or the safety of raised funds [3][8]. Purpose and Source of Funds - The purpose of cash management is to improve the efficiency of raised funds and increase returns for the company and its shareholders while ensuring normal operations and project construction [5][11]. - The funds for cash management come from temporarily idle raised funds, which were raised through an initial public offering totaling approximately 761.8563 million yuan, with a net amount of 678.5604 million yuan after deducting issuance costs [7][11]. Risk Management - The cash management products are characterized as principal-protected and floating yield, ensuring high safety and liquidity [4][11]. - The company will select reputable financial institutions for cash management and will monitor the investment products closely to mitigate risks [9][10]. Impact on Company - The use of idle raised funds for cash management will not adversely affect the company's main business or the implementation of investment projects, while also potentially increasing returns for shareholders [11].

Core Viewpoint - Kunming Pharmaceutical Group Co., Ltd. plans to invest up to 2.5 billion yuan of idle self-owned funds in low to medium-risk financial products to enhance fund utilization efficiency and yield levels while ensuring operational capital needs and safety [1][5]. Investment Details - Investment Amount: 2.5 billion yuan [4] - Investment Type: Low to medium-risk financial products [4] - Source of Funds: Self-owned funds [4] Product Characteristics - The company intends to purchase high-security, low to medium-risk financial products (risk rating R2 and below), including bank wealth management products and structured deposits [5]. - The investment will not be directed towards high-risk securities market products such as stocks, bonds, funds, foreign exchange, and derivatives [5]. Investment Timeline - Investment period is within one year from the date of shareholder meeting approval, until October 9, 2026 [5]. - Each financial product's single investment term shall not exceed six months [5]. Company Background - Kunming Pharmaceutical Group was established in March 1951 and listed on the Shanghai Stock Exchange in December 2000 [5]. - The company has over 50 subsidiaries, including Kunming Traditional Chinese Medicine Factory and Kunming Huaren Shenghuo Pharmaceutical Co., Ltd. [5]. - In the first half of 2023, the company achieved operating revenue of 3.351 billion yuan and a net profit attributable to shareholders of 198 million yuan [5].

Core Viewpoint - China Resources Sanjiu (华润三九) announced plans to invest up to 10 billion yuan in bank wealth management products to effectively utilize idle funds while ensuring operational safety and risk management [1] Investment Strategy - The company aims to invest a total of no more than 10 billion yuan of its own funds in bank and bank-affiliated wealth management products, excluding those from Zhuhai China Resources Bank [1] - The investment will focus on medium to low-risk financial products and structured deposits, ensuring that it does not affect the company's main business operations [1] Risk Management Principles - The company adheres to principles of "standardized operations, risk prevention, cautious investment, and value preservation and appreciation" [1] - The strategy is designed to generate investment returns for shareholders while maintaining the safety of the company's daily operations and funds [1]